한빛사논문 | BRIC

이재철 님의 논문 목록

울산대학교 의과대학, 서울아산병원

Safety and efficacy of SNK01 (autologous natural killer cells) in combination with cytotoxic chemotherapy and/or cetuximab after failure of prior tyrosine kinase inhibitor in non-small cell lung cancer: non-clinical mouse model and phase I/IIa clinical study
- J. Immunother. Cancer, Mar 27 2024, 12 (3) e008585 | https://doi.org/10.1136/jitc-2023-008585
- 2024-03
- 의약학
- 한빛사논문
Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
- Exp. Mol. Med., Published 09 August 2019 | https://doi.org/10.1038/s12276-019-0295-2
- 2019-08
- 상위피인용논문
Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs
- Lung Cancer, Volume 73, Issue 2, August 2011, Pages 176-182 | https://doi.org/10.1016/j.lungcan.2010.11.011
- 2011-08
- 상위피인용논문
Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line
- Lung Cancer, Volume 63, Issue 2, February 2009, Pages 219-226 | https://doi.org/10.1016/j.lungcan.2008.05.017
- 2009-02
- 상위피인용논문
- 이재철(울산의대,서울아산병원)
  Interview
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
- Nat. Genet., 44, 852–860 (2012). Published online 01 July 2012 | doi:10.1038/ng.2330
- 2012-07
- 한빛사논문, 상위피인용논문

저자논문